Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy L Jenkins

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Molecular Informatics|August 2, 2016
Large-Scale QSAR in Target Prediction and Phenotypic HTS AssessmentJeremy L Jenkins
Nature Chemical Biology|October 22, 2013
Drug discovery: Rethinking cellular drug responseJeremy L Jenkins
Drug Discovery Today|August 15, 2015
Identifying compound efficacy targets in phenotypic drug discoveryMarkus Schirle, Jeremy L Jenkins
Methods in Molecular Biology (Clifton, N.J.)|September 4, 2009
Chemogenomic analysis of safety profiling dataJosef Scheiber, Jeremy L Jenkins
Biochemistry|June 5, 2003
Identification of small-molecule inhibitors of human angiogenin and characterization of their binding interactions guided by computational dockingJeremy L Jenkins, Robert Shapiro
Methods in Molecular Biology (Clifton, N.J.)|May 9, 2018
Quantitative Prioritization of Tool Compounds for Phenotypic ScreeningYuan Wang, Jeremy L Jenkins
Nature Chemical Biology|February 16, 2010
Phenotypic screening: Fishing for neuroactive compoundsJeremy L Jenkins, Laszlo Urban
Journal of Medicinal Chemistry|November 30, 2004
A 3D similarity method for scaffold hopping from known drugs or natural ligands to new chemotypesJeremy L Jenkins, Meir Glick, John W Davies
Current Opinion in Chemical Biology|July 11, 2006
Streamlining lead discovery by aligning in silico and high-throughput screeningJohn W Davies, Meir Glick, Jeremy L Jenkins
Journal of Chemical Information and Modeling|November 22, 2011
Activity-aware clustering of high throughput screening data and elucidation of orthogonal structure-activity relationshipsEugen Lounkine, Florian Nigsch, Jeremy L Jenkins, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Molecular Informatics|August 2, 2016
Large-Scale QSAR in Target Prediction and Phenotypic HTS AssessmentJeremy L Jenkins
Nature Chemical Biology|October 22, 2013
Drug discovery: Rethinking cellular drug responseJeremy L Jenkins
Drug Discovery Today|August 15, 2015
Identifying compound efficacy targets in phenotypic drug discoveryMarkus Schirle, Jeremy L Jenkins
Methods in Molecular Biology (Clifton, N.J.)|September 4, 2009
Chemogenomic analysis of safety profiling dataJosef Scheiber, Jeremy L Jenkins
Biochemistry|June 5, 2003
Identification of small-molecule inhibitors of human angiogenin and characterization of their binding interactions guided by computational dockingJeremy L Jenkins, Robert Shapiro
Methods in Molecular Biology (Clifton, N.J.)|May 9, 2018
Quantitative Prioritization of Tool Compounds for Phenotypic ScreeningYuan Wang, Jeremy L Jenkins
Nature Chemical Biology|February 16, 2010
Phenotypic screening: Fishing for neuroactive compoundsJeremy L Jenkins, Laszlo Urban
Journal of Medicinal Chemistry|November 30, 2004
A 3D similarity method for scaffold hopping from known drugs or natural ligands to new chemotypesJeremy L Jenkins, Meir Glick, John W Davies
Current Opinion in Chemical Biology|July 11, 2006
Streamlining lead discovery by aligning in silico and high-throughput screeningJohn W Davies, Meir Glick, Jeremy L Jenkins
Journal of Chemical Information and Modeling|November 22, 2011
Activity-aware clustering of high throughput screening data and elucidation of orthogonal structure-activity relationshipsEugen Lounkine, Florian Nigsch, Jeremy L Jenkins, et al.
Pageof 7